Systemtherapie des kolorektalen Karzinoms
作者： B. C. Pestalozzi , D. Jäger , A. Knuth
DOI: 10.1007/S00104-005-1038-6
关键词: Bevacizumab 、 Cardiothoracic surgery 、 Capecitabine 、 Gynecology 、 Cetuximab 、 Abdominal surgery 、 Irinotecan 、 Vascular surgery 、 Medicine 、 Oxaliplatin
摘要: Die medikamentose Behandlung des kolorektalen Karzinoms hat in den letzten 10 Jahren eindruckliche Fortschritte gemacht. Neben dem altbewahrten 5-Fluorouracil stehen heute neue Zytostatika zur Verfugung wie Irinotecan und Oxaliplatin. Monoklonale Antikorper Bevacizumab Cetuximab haben erfolgreich Eingang aktuelle Therapiestrategien gefunden. Auf der Basis randomisierter klinischer Studien lassen sich rationale formulieren, diesem Beitrag dargestellt.
springer.com
sci-hub.se 参考文章(16)
Paulo M. Hoff, Rafat Ansari, Gerald Batist, John Cox, Walter Kocha, Mario Kuperminc, Jean Maroun, David Walde, Charles Weaver, Evelyn Harrison, Hans U. Burger, Bruno Osterwalder, Alfred O. Wong, Ralf Wong, Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study Journal of Clinical Oncology. ,vol. 19, pp. 2282- 2292 ,(2001) , 10.1200/JCO.2001.19.8.2282
C.-H. Köhne, E. Van Cutsem, J. Wils, C. Bokemeyer, M. El-Serafi, M. Lutz, M. Lorenz, O. Anak, B. Genicot, B. Nordlinger, 1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986 Ejc Supplements. ,vol. 1, ,(2003) , 10.1016/S1359-6349(03)91114-1
Alberto F. Sobrero, Scheduling of fluorouracil: a forget-me-not in the jungle of doublets. Journal of Clinical Oncology. ,vol. 22, pp. 4- 6 ,(2004) , 10.1200/JCO.2004.11.974
A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, A. Bonetti, Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer Journal of Clinical Oncology. ,vol. 18, pp. 2938- 2947 ,(2000) , 10.1200/JCO.2000.18.16.2938
Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, Brian P. Findlay, Henry C. Pitot, Steven R. Alberts, A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 22, pp. 23- 30 ,(2004) , 10.1200/JCO.2004.09.046
JY Douillard, D Cunningham, AD Roth, M Navarro, RD James, P Karasek, P Jandik, T Iveson, J Carmichael, M Alakl, G Gruia, L Awad, P Rougier, Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial The Lancet. ,vol. 355, pp. 1041- 1047 ,(2000) , 10.1016/S0140-6736(00)02034-1
Christophe Tournigand, Thierry André, Emmanuel Achille, Gérard Lledo, Michel Flesh, Dominique Mery-Mignard, Emmanuel Quinaux, Corinne Couteau, Marc Buyse, Gérard Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont, FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study Journal of Clinical Oncology. ,vol. 22, pp. 229- 237 ,(2004) , 10.1200/JCO.2004.05.113
Kaoru Kubota, Koshiro Watanabe, Hideo Kunitoh, Kazumasa Noda, Yukito Ichinose, Nobuyuki Katakami, Takahiko Sugiura, Masaaki Kawahara, Akira Yokoyama, Soichiro Yokota, Shuichi Yoneda, Kaoru Matsui, Shinzo Kudo, Masahiko Shibuya, Takeshi Isobe, Yoshihiko Segawa, Yutaka Nishiwaki, Yasuo Ohashi, Hisanobu Niitani, Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group Journal of Clinical Oncology. ,vol. 22, pp. 254- 261 ,(2004) , 10.1200/JCO.2004.06.114
Eric Van Cutsem, Chris Twelves, Jim Cassidy, David Allman, Emilio Bajetta, Michael Boyer, Roland Bugat, Mike Findlay, Stefan Frings, Michaela Jahn, Joe McKendrick, Bruno Osterwalder, Gumersindo Perez-Manga, Riccardo Rosso, Philippe Rougier, Wolff H. Schmiegel, Jean-Francois Seitz, Paul Thompson, Jose Maria Vieitez, Christof Weitzel, Peter Harper, Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study Journal of Clinical Oncology. ,vol. 19, pp. 4097- 4106 ,(2001) , 10.1200/JCO.2001.19.21.4097
David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, Danny Bets, Matthias Mueser, Andreas Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem, None, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. The New England Journal of Medicine. ,vol. 351, pp. 337- 345 ,(2004) , 10.1056/NEJMOA033025